Article
Predictive efficacy of low burden EGFR mutation detected by next-generation sequencing on response to EGFR tyrosine kinase inhibitors in non-small-cell lung carcinoma.
PloS one - 1 Jan 2013
Kim Hye Sook, Sung Jae Sook, Yang Song-Ju, Kwon Nak-Jung, Jin LiHua, Kim Seung Tae, Park Kyong Hwa, Shin Sang Won, Kim Han Kyeom, Kang Jin-Hyoung, Kim Jeong-Oh, Park Jae Yong, Choi Jin Eun, Yoon HyoungKyu, Park Chan Kwon, Yang Kap-Seok, Seo Jeong-Sun, Kim Yeul Hong
Abstract excerpt
Direct sequencing remains the most widely used method for the detection of epidermal growth factor receptor (EGFR) mutations in lung cancer; however, its relatively low sensitivity limits its clinical use. The objective of this study was to investigate the sensitivity of detecting an epidermal growth factor receptor (EGFR) mutation from peptide nucleic acid-locked nucleic acid polymerase chain reaction (PNA-LNA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
